CD36 and metabolic dysfunction-associated steatotic liver disease: It has been reported that the levels of the CD36 protein are increased in nonalcoholic fatty liver disease (NAFLD) patients, which is associated with dyslipidemia, obesity, and type 2 diabetes25.